a month ago
ARCT
AnalystsYigal NochomovitzYigal Nochomovitz's Stock Forecasts
AnalystsYigal Nochomovitz
Sectors:
Analyst Ranking
Top 10%
#477 out of 5014 analysts
Average Return
+7.11%
Win Rate
46%115 out of 249
Risk vs Reward
Poor
Good
Yigal Nochomovitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Applied Therapeutics IncAPLT | +640.00% | $0.80 | $5.92 | 2023-04-05 - 2024-04-04 | Strong Buy |
Harpoon Therapeutics IncHARP | +381.72% | $4.76 | $22.93 | 2023-09-18 - 2024-02-26 | Strong Buy |
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-09 - 2023-08-01 | Strong Buy |
Harpoon Therapeutics IncHARP | +327.80% | $5.36 | $22.93 | 2023-10-24 - 2024-02-26 | Strong Buy |
Summit Therapeutics IncSMMT | +293.31% | $5.31 | $20.89 | 2024-05-07 - 2024-09-27 | Strong Buy |
Yigal Nochomovitz Analyst Color
Get additional color on Yigal Nochomovitz's coverage of popular stocks
a month ago
OLMA
a month ago
ZLAB
a month ago
ZYME
a month ago
LXRX
a month ago
SNDX
a month ago
LENZ
a month ago
LENZ
2 months ago
PROK
6 months ago
SMMT
6 months ago
LENZ
6 months ago
RIGL
9 months ago
MRUS
10 months ago
APLT
10 months ago
SNDX
a year ago
SMMT
a year ago
APLT
a year ago
AVBP
a year ago
SMMT
a year ago
APLT
a year ago
SNDX
a year ago
ONC
a year ago
ARDX
a year ago
MRUS
a year ago
RCUS
Yigal Nochomovitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arrivent Biopharma IncAVBP | 3 | Strong Buy | $33.00 | +67.43% | Maintains | a month ago |
Arcturus Therapeutics Holdings IncARCT | 6 | Strong Buy | $49.00 | +182.91% | Maintains | a month ago |
Olema Pharmaceuticals IncOLMA | 2 | Strong Buy | $21.00 | +170.27% | Maintains | a month ago |
Zai Lab LtdZLAB | 8 | Strong Buy | $69.00 | +110.37% | Maintains | a month ago |
Biomea Fusion IncBMEA | 10 | Strong Buy | $7.00 | +262.69% | Maintains | a month ago |
Zymeworks IncZYME | 13 | Strong Buy | $22.00 | +39.77% | Maintains | a month ago |
Lexicon Pharmaceuticals IncLXRX | 6 | Strong Buy | $1.90 | +65.22% | Maintains | a month ago |
Syndax Pharmaceuticals IncSNDX | 9 | Strong Buy | $51.00 | +227.97% | Maintains | a month ago |
Krystal Biotech IncKRYS | 6 | Hold | $166.00 | +15.53% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 15 | Strong Buy | $52.00 | +109.26% | Maintains | a month ago |
Lenz Therapeutics IncLENZ | 4 | Strong Buy | $52.00 | +25.80% | Maintains | a month ago |
Sarepta Therapeutics IncSRPT | 1 | Strong Sell | $7.00 | -59.75% | Initiates Coverage On | 2 months ago |
Prokidney CorpPROK | 2 | Strong Buy | $9.00 | +262.90% | Maintains | 2 months ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $14.00 | +159.74% | Initiates Coverage On | 3 months ago |
Arvinas IncARVN | 9 | Hold | $9.50 | +22.74% | Maintains | 4 months ago |
Ardelyx IncARDX | 11 | Strong Buy | $10.00 | +51.29% | Maintains | 4 months ago |
Summit Therapeutics IncSMMT | 5 | Strong Buy | $35.00 | +84.79% | Upgrades | 6 months ago |
Rigel Pharmaceuticals IncRIGL | 11 | Strong Buy | $55.00 | +44.89% | Maintains | 6 months ago |
Candel Therapeutics IncCADL | 1 | Strong Buy | $25.00 | +421.92% | Initiates Coverage On | 7 months ago |
Crispr Therapeutics AgCRSP | 18 | Strong Buy | $82.00 | +45.75% | Maintains | 7 months ago |
Eyepoint Pharmaceuticals IncEYPT | 1 | Strong Buy | $33.00 | +147.19% | Initiates Coverage On | 8 months ago |
Merus NvMRUS | 14 | Strong Buy | $97.00 | +39.41% | Maintains | 9 months ago |
Applied Therapeutics IncAPLT | 8 | Strong Buy | $8.00 | +1,800.24% | Maintains | 10 months ago |
Caribou Biosciences IncCRBU | 5 | Strong Buy | $6.00 | +233.33% | Maintains | 10 months ago |
Zenas Biopharma IncZBIO | 1 | Strong Buy | $27.00 | +33.47% | Initiates Coverage On | a year ago |
Shattuck Labs IncSTTK | 4 | Hold | $2.00 | +4.17% | Downgrades | a year ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | $58.00 | N/A | Maintains | a year ago |
Macrogenics IncMGNX | 10 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Beone Medicines LtdONC | 4 | Strong Buy | $288.00 | N/A | Maintains | a year ago |
Ovid Therapeutics IncOVID | 6 | Hold | $1.20 | N/A | Maintains | a year ago |
Arcus Biosciences IncRCUS | 6 | Strong Buy | $38.00 | N/A | Maintains | a year ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $39.00 | N/A | Downgrades | a year ago |
Oric Pharmaceuticals IncORIC | 5 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Proqr Therapeutics NvPRQR | 3 | Hold | $2.00 | N/A | Maintains | a year ago |
Harpoon Therapeutics IncHARP | 9 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Mirati Therapeutics IncMRTX | 11 | Hold | $59.00 | N/A | Downgrades | 2 years ago |
Aldeyra Therapeutics IncALDX | 8 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Rain Oncology IncRAIN2 | 4 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Eiger Biopharmaceuticals IncEIGRQ | 3 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Gracell Biotechnologies IncGRCL | 2 | Strong Buy | $11.00 | N/A | Maintains | 2 years ago |
Galera Therapeutics IncGRTX | 2 | Hold | $0.25 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 11 | Strong Sell | $35.00 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 8 | Hold | $172.50 | N/A | Downgrades | 2 years ago |
Ultragenyx Pharmaceutical IncRARE | 10 | Strong Buy | $133.00 | N/A | Maintains | 2 years ago |
Unity Biotechnology IncUNBX | 6 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Cellectis SaCLLS | 2 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Opthea LtdOPT | 2 | Strong Buy | $44.00 | N/A | Maintains | 3 years ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $32.00 | N/A | Downgrades | 4 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $171.00 | N/A | Maintains | 5 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Buy | $70.00 | N/A | Maintains | 7 years ago |
Loxo Oncology IncLOXO | 6 | Strong Buy | $213.00 | N/A | Maintains | 7 years ago |
Keryx Biopharmaceuticals IncKERX | 2 | Hold | $4.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.